The case for targeted screening programs for lung cancer has been bolstered by results from the European NELSON study, a leading UK clinician argues. Professor David Baldwin, consultant respiratory physician in Nottingham and a member of NHS England’s advisory group on lung cancer, said the long-awaited results from the NELSON study meant there would likely ...
Case for targeted lung cancer screening bolstered by NELSON results, experts say
By Emma Wilkinson
4 Mar 2020